Witryna13 kwi 2024 · In patients with late-onset Pompe disease (LOPD), the efficacy of the enzyme replacement therapy (ERT) with recombinant human alpha-glucosidase … Witryna28 lip 2024 · At present, enzyme replacement therapy (ERT) with alglucosidase alfa is the only specific treatment available. It modestly improves mobility and stabilizes respiratory function in patients with LOPD [ 5 ]. Recently, low bone mineral density (BMD) and osteoporosis has been reported in LOPD [ 6, 7 ].
Enzyme replacement therapy for mucopolysaccharidoses; past, …
Witryna11 kwi 2024 · This would represent a substantial improvement over currently marketed enzyme replacement therapies. However, further clinical evaluation will still be required to support these claims. ... Since Gaucher s disease results due to mutation in a single gene, it is possible to treat the disease by enzyme replacement therapy (ERT), … WitrynaEnzyme replacement therapy in Pompe disease (glycogen storage disease type 2) improves cardiomyopathy and cardiac functions . It has been shown that it can reduce neuropathic pain and alleviates gastrointestinal symptoms and improves pulmonary functions in Fabry disease, while in Gaucher disease, significant improvement in … honig conan exiles
Improvement of dysphagia in a child affected by Pompe disease …
Witryna16 lis 2024 · Enzyme replacement therapy (ERT), based on the periodic intravenous administration of specific enzymes produced with recombinant DNA technology, is at … Witryna28 lip 2024 · The biggest improvement, 84.4% increase in BMD, was seen in a lady with the most prominent weight recovery. Our results suggest that ERT improves BMD in … Witryna2 wrz 2003 · Background— Enzyme replacement therapy (ERT) has been shown to enhance microvascular endothelial globotriaosylceramide clearance in the hearts of patients with Fabry disease. Whether these … honigchampignons